CS545686A1 - Farmaceuticky prostredek a antihepatotoxickym pusobenim - Google Patents

Farmaceuticky prostredek a antihepatotoxickym pusobenim

Info

Publication number
CS545686A1
CS545686A1 CS865456A CS545686A CS545686A1 CS 545686 A1 CS545686 A1 CS 545686A1 CS 865456 A CS865456 A CS 865456A CS 545686 A CS545686 A CS 545686A CS 545686 A1 CS545686 A1 CS 545686A1
Authority
CS
Czechoslovakia
Prior art keywords
flavanolignanes
phospholipids
pusobenim
antihepatotoxickym
farmaceuticky
Prior art date
Application number
CS865456A
Other languages
English (en)
Other versions
CS261637B1 (en
Inventor
Ezio Bombardelli
Maria Jose Magistretti
Original Assignee
Ezio Bombardelli
Maria Jose Magistretti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11184200&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CS545686(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ezio Bombardelli, Maria Jose Magistretti filed Critical Ezio Bombardelli
Publication of CS545686A1 publication Critical patent/CS545686A1/cs
Publication of CS261637B1 publication Critical patent/CS261637B1/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Detergent Compositions (AREA)
CS865456A 1985-07-17 1986-07-17 Antihepatotoxic pharmaceutical preparat CS261637B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21603/85A IT1187687B (it) 1985-07-17 1985-07-17 Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi

Publications (2)

Publication Number Publication Date
CS545686A1 true CS545686A1 (en) 1988-07-15
CS261637B1 CS261637B1 (en) 1989-02-10

Family

ID=11184200

Family Applications (1)

Application Number Title Priority Date Filing Date
CS865456A CS261637B1 (en) 1985-07-17 1986-07-17 Antihepatotoxic pharmaceutical preparat

Country Status (6)

Country Link
EP (1) EP0209037B1 (cs)
JP (1) JPS6222719A (cs)
AT (1) ATE50499T1 (cs)
CS (1) CS261637B1 (cs)
DE (1) DE3669106D1 (cs)
IT (1) IT1187687B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190370B (it) * 1985-06-19 1988-02-16 Zambon Spa Composizione farmaceutica solida per uso orale
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
DE4401902C2 (de) * 1994-01-24 2000-02-03 Madaus Ag Verwendung von Flavolignanen als Adjuvans in der Tumortherapie
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
CN1061239C (zh) * 1995-01-20 2001-01-31 李叔文 爱滋病特效治疗剂
RU2133122C1 (ru) * 1998-10-14 1999-07-20 Научно-исследовательский институт биомедицинской химии РАМН Композиция, обладающая свойствами репарировать биологические мембраны
US6979459B1 (en) 2000-04-06 2005-12-27 Perricone Nicholas V Treatment of skin damage using polyenylphosphatidycholine
US6191121B1 (en) * 2000-04-06 2001-02-20 Nicholas V. Perricone Treatment of skin damage using polyenylphosphatidylcholine
US6932963B2 (en) 2000-06-23 2005-08-23 Nicholas V. Perricone Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
ATE363486T1 (de) 2001-07-27 2007-06-15 Neptune Technologies & Bioress Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen
DE60217381D1 (de) * 2001-10-25 2007-02-15 Vladimir Leko Zusammensetzung zum schutz und zur regeneration von leberstruktur und -funktion
US8052992B2 (en) 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
RU2283114C1 (ru) * 2005-06-07 2006-09-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Композиция, обладающая гепатопротекторной активностью и нормализующая обменные процессы
WO2010150051A1 (de) * 2009-06-24 2010-12-29 Lipoid Gmbh Zusammensetzung für kosmetische, pharmazeutische oder diätetische anwendungen
MX2012004977A (es) 2009-10-29 2012-11-06 Acasti Pharma Inc Composiciones fosfolipídicas terapéuticas concentradas.
CN105816422B (zh) 2015-01-05 2020-08-14 天士力医药集团股份有限公司 一种水飞蓟宾注射剂及其制备方法
CN105983016B (zh) 2015-03-23 2023-08-11 天士力医药集团股份有限公司 一种含有水飞蓟宾的药物组合
CN105983018B (zh) * 2015-03-23 2022-06-03 天士力医药集团股份有限公司 一种含有水飞蓟宾的药物组合物
ITUB20155532A1 (it) * 2015-11-12 2017-05-12 St Biochimico Italiano Giovanni Lorenzini Spa Formulazione farmaceutica orale comprendente silibina
EP3703724A1 (en) 2017-11-02 2020-09-09 NatureCeuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5060M (cs) * 1965-12-22 1967-05-08
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees

Also Published As

Publication number Publication date
ATE50499T1 (de) 1990-03-15
JPS6222719A (ja) 1987-01-30
DE3669106D1 (de) 1990-04-05
EP0209037A1 (en) 1987-01-21
IT1187687B (it) 1987-12-23
CS261637B1 (en) 1989-02-10
EP0209037B1 (en) 1990-02-28
IT8521603A0 (it) 1985-07-17

Similar Documents

Publication Publication Date Title
CS545686A1 (en) Farmaceuticky prostredek a antihepatotoxickym pusobenim
IE862554L (en) Pharmaceutical compositions
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
MY118371A (en) Tetrahydrolipstatin containing compositions
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
EP0552256A4 (cs)
NZ226923A (en) 5'-deoxy-5-fluorocytidine derivatives and pharmaceutical compositions
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
IT1177152B (it) Procedimento e composizione per la preparazione di prodotti farmaceutici ad azione prolungata controllata per la somministrazione orale
SE8402560D0 (sv) Farmaceutisk komposition
EP0513702A3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
GB8623557D0 (en) Therapeutic agents
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
NZ215186A (en) 13 alkoxymethoxy avermectin derivatives and pharmaceutical compositions
IL86798A (en) 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
ZA898667B (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment
NZ218749A (en) 5 to 8-membered azacyclic derivatives and pharmaceutical compositions
IL78336A (en) Compositions for delivery of orally administered fat-soluble drugs
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
DK0437294T3 (da) Orale farmaceutiske præparater i enhedsdosisform
GR3032874T3 (en) Gel-like pharmaceutical compositions containing chondroitin sulfate salts suitable for oral administration
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
TW263437B (cs)
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it